Halofuginone, a collagen type I inhibitor improves liver regeneration in cirrhotic rats (Q44100200)

29 November 2017

Halofuginone, a collagen type I inhibitor improves liver regeneration in cirrhotic rats (English)

1 reference

29 November 2017

0 references

Gadi Spira

1

1 reference

29 November 2017

Nidal Mawasi

2

1 reference

29 November 2017

Melia Paizi

3

1 reference

29 November 2017

Natali Anbinder

4

1 reference

29 November 2017

Olga Genina

5

1 reference

29 November 2017

Rosaly Alexiev

6

1 reference

29 November 2017

Mark Pines

7

1 reference

29 November 2017

1 September 2002

1 reference

29 November 2017

Journal of Hepatology

1 reference

29 November 2017

37

1 reference

29 November 2017

331-339

1 reference

29 November 2017

3

1 reference

The epidemiology and prevention of hepatocellular carcinoma

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Pathogenesis of liver fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Collagens of normal and cirrhotic human liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Changes in albumin, alpha-fetoprotein and collagen gene transcription in CCl4-induced hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

C. L. Oakley Lecture (1993). Cellular and molecular aspects of hepatic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Tissue inhibitors of metalloproteinases in liver fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Tissue inhibitor of metalloproteinase-1 in the liver of patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Differential distribution of five members of the matrix metalloproteinase family and one inhibitor (TIMP-1) in human liver and skin.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Halofuginone: a novel antifibrotic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Inhibition of collagen type I synthesis by skin fibroblasts of graft versus host disease and scleroderma patients: effect of halofuginone

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Inhibition of collagen synthesis and changes in skin morphology in murine graft-versus-host disease and tight skin mice: effect of halofuginone

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Reduction in pulmonary fibrosis in vivo by halofuginone

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Topically applied halofuginone, an inhibitor of collagen type I transcription, reduces peritendinous fibrous adhesions following surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Halofuginone--an inhibitor of collagen type I synthesis--prevents postoperative formation of abdominal adhesions

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Halofuginone, an inhibitor of collagen type I synthesis, prevents postoperative adhesion formation in the rat uterine horn model

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Topical treatment of cutaneous chronic graft versus host disease with halofuginone: a novel inhibitor of collagen type I synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Halofuginone, a specific inhibitor of collagen type I synthesis, prevents dimethylnitrosamine-induced liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

A simple and sensitive method for the quantitative estimation of collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Perioperative continuous hepatocyte growth factor supply prevents postoperative liver failure in rats with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Differential expression of apoptosis-associated genes post-hepatectomy in cirrhotic vs. normal rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Stimulation of liver regeneration and function after partial hepatectomy in cirrhotic rats by continuous infusion of recombinant human hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Hepatic collagen synthesis and degradation during liver regeneration after partial hepatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Expression and activation of pro-MMP-2 and pro-MMP-9 during rat liver regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Hepatocyte growth factor gene therapy of liver cirrhosis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Adenosine reverses a preestablished CCl4-induced micronodular cirrhosis through enhancing collagenolytic activity and stimulating hepatocyte cell proliferation in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Reduction in dermal fibrosis in the tight-skin (Tsk) mouse after local application of halofuginone

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Inhibition of neovascularization and tumor growth, and facilitation of wound repair, by halofuginone, an inhibitor of collagen type I synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-beta-mediated Smad3 activation in fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

The extracellular matrix in hepatic regeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Halofuginone, a specific collagen type I inhibitor, reduces anastomotic intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Separate cis-acting DNA elements of the mouse pro-alpha 1(I) collagen promoter direct expression of reporter genes to different type I collagen-producing cells in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Effect of vascular endothelial growth factor on hepatic regenerative activity following partial hepatectomy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

Vascular endothelial growth factor and angiopoietin in liver regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900164-2

7 January 2021

10.1016/S0168-8278(02)00164-2

Identifiers

DOI

1 reference

29 November 2017

1 reference